Media Summary: Dr. Jamile Shammo, Rush University Medical Center, Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the characteristic mutation patterns in ... James M. Foran, MD, FRCP, and Azra Raza, MD, explain how
What Is Mds How Do We Determine Prognosis - Detailed Analysis & Overview
Dr. Jamile Shammo, Rush University Medical Center, Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the characteristic mutation patterns in ... James M. Foran, MD, FRCP, and Azra Raza, MD, explain how A roundtable discussion, moderated by Amer Zeidan, MBBS, MHS, of Yale University, focused on the latest updates in the care of ... Felicitas Thol, MD, Hannover Medical School, Hannover, Germany, discusses the use of Drorit Merkel, MD, Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel, discusses the unmet need for novel ...
Argiris Symeonidis, MD, PhD, University of Patras, Patras, Greece, discusses the Doctor Azra Raza, MD from Columbia University Medical Center Watch the full course and our most up-to-date content here: Create a free account to track ... Eric Solary, MD, Gustave Roussy Institute, Paris, France, outlines currently used David Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, discusses myelodysplastic syndromes ( What are myelodysplastic syndromes? Myelodysplastic syndromes, or
Genetic mutations have been shown to have Moshe Mittelman, MD, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel, discusses approaches to
